RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
OrthoPediatrics Stock

OrthoPediatrics Revenue 2024

OrthoPediatrics Revenue

205.69 M USD

Ticker

KIDS

ISIN

US68752L1008

WKN

A2JAAV

In 2024, OrthoPediatrics's sales reached 205.69 M USD, a 38.3% difference from the 148.73 M USD sales recorded in the previous year.

The OrthoPediatrics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2026e286.5138,83
2025e244.145,58
2024e205.6954,09
2023148.7374,80
2022122.374,16
20219874,90
202071.177,36
201972.675,21
201857.674,13
201745.675,66
201637.370,78
20153169,68
201423.770,04

OrthoPediatrics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into OrthoPediatrics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OrthoPediatrics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OrthoPediatrics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of OrthoPediatrics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into OrthoPediatrics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing OrthoPediatrics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OrthoPediatrics’s growth potential.

OrthoPediatrics Revenue, EBIT and net profit per share

DateOrthoPediatrics RevenueOrthoPediatrics EBITOrthoPediatrics Net Income
2026e286.51 M undefined-13.21 M undefined-22.67 M undefined
2025e244.1 M undefined-21.92 M undefined-29.27 M undefined
2024e205.69 M undefined-27.21 M undefined-29.36 M undefined
2023148.73 M undefined-25.77 M undefined-20.97 M undefined
2022122.3 M undefined-21.4 M undefined1.3 M undefined
202198 M undefined-17.5 M undefined-16.3 M undefined
202071.1 M undefined-19.5 M undefined-32.9 M undefined
201972.6 M undefined-8.4 M undefined-13.7 M undefined
201857.6 M undefined-9.6 M undefined-12 M undefined
201745.6 M undefined-6.5 M undefined-23.5 M undefined
201637.3 M undefined-4.1 M undefined-12.4 M undefined
201531 M undefined-6.6 M undefined-12.7 M undefined
201423.7 M undefined-7.1 M undefined-12.8 M undefined

OrthoPediatrics stock margins

The OrthoPediatrics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OrthoPediatrics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OrthoPediatrics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the OrthoPediatrics's sales revenue. A higher gross margin percentage indicates that the OrthoPediatrics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the OrthoPediatrics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the OrthoPediatrics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OrthoPediatrics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OrthoPediatrics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OrthoPediatrics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

OrthoPediatrics Margin History

OrthoPediatrics Gross marginOrthoPediatrics Profit marginOrthoPediatrics EBIT marginOrthoPediatrics Profit margin
2026e74.8 %-4.61 %-7.91 %
2025e74.8 %-8.98 %-11.99 %
2024e74.8 %-13.23 %-14.27 %
202374.8 %-17.32 %-14.1 %
202274.16 %-17.5 %1.06 %
202174.9 %-17.86 %-16.63 %
202077.36 %-27.43 %-46.27 %
201975.21 %-11.57 %-18.87 %
201874.13 %-16.67 %-20.83 %
201775.66 %-14.25 %-51.54 %
201670.78 %-10.99 %-33.24 %
201569.68 %-21.29 %-40.97 %
201470.04 %-29.96 %-54.01 %

OrthoPediatrics Aktienanalyse

What does OrthoPediatrics do?

OrthoPediatrics Corp is an American company specializing in products and solutions for orthopedic disorders in children and adolescents. The company was founded in 2006 and is headquartered in Warsaw, Indiana. Business model: The business model of OrthoPediatrics Corp focuses on the development and marketing of implants and surgical instruments for the treatment of orthopedic disorders in children and adolescents. The company works closely with specialists and hospitals to develop innovative and specialized products that meet the needs of children and adolescents. The company specializes in three areas: 1. Trauma and deformity correction – treatment of spinal and limb injuries as well as congenital deformity disorders in children and adolescents. 2. Scoliosis and spinal surgery – correction of spinal deformity and treatment of scoliosis and kyphosis in children and adolescents. 3. Sports medicine and orthobiology – development of solutions to support bone healing and regeneration in children and adolescents after an injury or surgery. Products: OrthoPediatrics Corp offers a variety of products tailored to the specific needs and requirements of children and adolescents. These include: - Bands and implants for repairing broken bones and joint injuries. - Surgical instruments and implants for correcting spinal and limb deformities such as scoliosis. - Technologies to promote bone healing and regeneration, such as BioCartilage and Pedigree matrix. OrthoPediatrics Corp also has partnerships with other companies, such as Bioretec and PhyzioMedics, to develop innovative products and solutions that meet the needs of children and adolescents. Conclusion: OrthoPediatrics Corp is a leading provider of orthopedic solutions for children and adolescents. The company has a long history and an excellent reputation for developing innovative products and solutions tailored to the specific needs and requirements of this age group. The company works closely with specialists and hospitals to ensure that its products meet the highest medical standards and effectively help patients. OrthoPediatrics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding OrthoPediatrics's Sales Figures

The sales figures of OrthoPediatrics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing OrthoPediatrics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize OrthoPediatrics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in OrthoPediatrics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about OrthoPediatrics stock

How much revenue did OrthoPediatrics generate this year?

OrthoPediatrics has achieved a revenue of 205.69 M USD this year.

How much was the turnover of the company OrthoPediatrics compared to the previous year?

The revenue of OrthoPediatrics has increased by 38.3% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of OrthoPediatrics?

The revenue of OrthoPediatrics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of OrthoPediatrics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of OrthoPediatrics so important for investors?

The revenue of OrthoPediatrics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does OrthoPediatrics pay?

Over the past 12 months, OrthoPediatrics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OrthoPediatrics is expected to pay a dividend of 0 USD.

What is the dividend yield of OrthoPediatrics?

The current dividend yield of OrthoPediatrics is .

When does OrthoPediatrics pay dividends?

OrthoPediatrics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OrthoPediatrics?

OrthoPediatrics paid dividends every year for the past 0 years.

What is the dividend of OrthoPediatrics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OrthoPediatrics located?

OrthoPediatrics is assigned to the 'Health' sector.

Wann musste ich die Aktien von OrthoPediatrics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OrthoPediatrics from 9/26/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/26/2024.

When did OrthoPediatrics pay the last dividend?

The last dividend was paid out on 9/26/2024.

What was the dividend of OrthoPediatrics in the year 2023?

In the year 2023, OrthoPediatrics distributed 0 USD as dividends.

In which currency does OrthoPediatrics pay out the dividend?

The dividends of OrthoPediatrics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von OrthoPediatrics

Our stock analysis for OrthoPediatrics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OrthoPediatrics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.